Skip to main content

Opioid maker Collegium buys N.C. competitor for $604M

The Stoughton drug company is shelling out $604 million to buy a Raleigh, N.C.-based competitor called BioDelivery Sciences International Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.